|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Pension plan expenses | |||||
| Non-cash operating lease expense | |||||
| Amortization of deferred income | |||||
| Gain on deconsolidation of subsidiary | |||||
| Loss from equity method investment | |||||
| Net accretion of discounts on available-for-sale securities | |||||
| Deferred income taxes | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of property and equipment | |||||
| Purchases of available-for-sale securities and other | |||||
| Proceeds from maturities and sales of available-for-sale securities and other | |||||
| Payments relating to investment in equity method investment | |||||
| Proceeds from principal portion of related party loan | |||||
| Payments for business combination, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Payments of contingent consideration for business combination | |||||
| Principal payments under vendor financing arrangements | |||||
| Payments to tax authorities for shares withheld from employees | |||||
| Proceeds from exercise of stock options | |||||
| Payments of deferred offering costs | |||||
| Proceeds from employee stock purchase plan | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for taxes | |||||
| Noncash activities: | |||||
| Accrued deferred offering costs | |||||
| Operating lease right-of-use assets exchanged for lease liabilities | |||||
| Purchase of property and equipment through vendor financing | |||||
| Equity obtained in equity method investment in exchange for contribution of license agreement (Note 15) | |||||
| Issuance of common stock for business combination | |||||
| Contingent consideration for business combination | |||||
| Cash, cash equivalents and restricted cash at end of period: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, noncurrent | |||||
Loading...